US-headquartered broker Rosenblatt Securities has signed a deal to provide its clients with Chinese research.
A deal between Rosenblatt and China Merchants Securities (CMS) means research on Hong Kong and China stocks, corporate access and execution services will be available to US institutional investors.
Rosenblatt said this marks a significant milestone in its effort to provide clients with belt-in-class research from the region. CMS has over 100 research analysts across Hong Kong and China, providing cross border research covering hundreds of companies in a range of sectors.
“This new partnership with CMS completes the picture, while substantially expanding our overall coverage,” said Evan Morgan, managing director and head of research sales at Rosenblatt.
“And considering that recent volatility in China has highlighted the need for timely, in-depth analysis of China as both a supplier and consumer of technology, our timing for this launch couldn’t be better.”
Rosenblatt already offers research from other brokers in the region including SinoPac Securities in Taiwan, and has a global partnership network providing research on over 1,500 companies across 17 countries.
CMS added that the deal is a significant step in its plans to grow its gobal business and extend its international reach. It hopes to build on the success it experienced expanding into Hong Kong from mainland China with access to new US-based clients.